GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, CA12, CA2, CA7, CHRM1, CHRM3, CHRNA3, CHRNA7, CYP19A1, CYP1A1, CYP1B1, EDNRA, ESR1, FABP3, FABP4, FLT3, GAA, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HRH3, HRH4, HSD17B1, HSD17B2, KDR, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SLC1A1, SRC, XDH |
10.9615 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
8.06749 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, GRM1, GRM3, GRM5, GRM8 |
7.90472 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
7.58106 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CHRNA7, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GRIK5, HCAR2, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
7.44775 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
7.33869 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, GRIK5, GRM5, HSD17B2, IGF1R, MMP2, MMP9, PIK3CA, PPARA, PTGS2, SRC, TYR |
7.24796 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FUT7, GAA, GLO1, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH |
7.08764 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7 |
6.85049 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7 |
6.85049 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.79149 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GRIK5, HCAR2, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TOP2A, XDH |
6.66896 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
6.3642 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, CDC25B, CHRM5, CHRNA3, CHRNA7, EDNRA, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HRH3, HRH4, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
6.33347 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, CHRNA3, CHRNA7, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
6.33347 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, CHRNA3, CHRNA7, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
6.33347 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.33347 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, CDC25B, CHRM5, CHRNA3, CHRNA7, EDNRA, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HRH3, HRH4, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
6.2988 |
[BP] GO:0007187 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, GRM1, GRM3, GRM5, GRM8, HRH3 |
6.20998 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, AXL, CA12, CA2, CA7, CHRNA7, EDNRA, ESR1, FABP3, FABP4, FLT3, GAA, GRIK5, GRM1, GRM5, HRH4, MET, PIK3CA, PIK3CB, SRC |
6.16588 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GRIK5, HCAR2, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TOP2A, XDH |
6.13732 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
5.94254 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, APEX1, AXL, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, IGF1R, KDR, MMP2, PIK3CA, PPARA, PTGS2, SRC, TYR |
5.92436 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, AXL, CHRM1, CHRM3, CHRM5, CHRNA3, CHRNA7, CYP19A1, CYP1A2, CYP1B1, EDNRA, ESR1, FABP4, GAA, GRM1, GRM5, GRM8, HRH3, HSD17B2, IGF1R, MET, MGAM, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, SRC, TYR |
5.70175 |
[BP] GO:0007188 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, GRM1, GRM3, GRM5, GRM8 |
5.66632 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
5.50222 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
5.50222 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
5.41176 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
5.41176 |
[BP] GO:0060078 |
None
|
ADORA1, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM5 |
5.33584 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, GAA, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
5.25873 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.15444 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, HSD17B1, HSD17B2 |
5.15444 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, CA2, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, ESR1, FABP4, FLT3, FUT7, GAA, GLO1, HSD17B2, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, SRC, TOP2A, TYR |
4.94071 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2 |
4.88797 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3 |
4.88797 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
4.86985 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, APEX1, AXL, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, IGF1R, KDR, MMP2, MMP9, PIK3CA, PPARA, PTGS2, SRC, TYR |
4.79627 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APEX1, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, PTGS2, SRC |
4.7655 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2 |
4.75402 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, GRM1, GRM3, GRM5, GRM8, PTGS2 |
4.68897 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CHRM1, CHRM3, CHRM5, CYP1A1, EDNRA, ESR1, FLT3, MET, PIK3CB, PIM1, SRC, TYR |
4.66008 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, APEX1, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, PPARA, PTGS2, SRC |
4.62501 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PTGS2, SRC |
4.60113 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2 |
4.58352 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, CA2, CHRM1, CHRM2, CHRM3, CHRM5, EDNRA, ESR1, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, PIK3CA, PIK3CB, SRC |
4.57398 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, CYP2D6, ESR1, FABP4, GRM3, HRH3, HRH4, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
4.49856 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.48753 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRNA3, PTGS2 |
4.48753 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.41402 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA7, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH4, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.37626 |
[BP] GO:0060079 |
None
|
ADORA1, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 |
4.35553 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AXL, CA1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP1B1, EDNRA, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTPN1, SRC |
4.33598 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, CHRNA7, EDNRA, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, HRH4, MET, PIK3CA, PIK3CB |
4.32284 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AXL, CA2, CA7, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GRM1, HCAR2, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.31352 |
[BP] GO:1900543 |
None
|
EDNRA, GRM3, GRM8, HRH3, HRH4, PPARA |
4.3009 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC |
4.3009 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AXL, CA2, CA7, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GRM1, HCAR2, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.3009 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA7, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH4, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.2967 |
[BP] GO:0045980 |
None
|
EDNRA, GRM3, GRM8, HRH3, HRH4, PPARA |
4.28557 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, CA2, CA6, CA9, CHRM2, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HRH4, HSD17B2, IGF1R, KDR, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TYR |
4.24155 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.22156 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, FABP3, PPARA, SLC1A1 |
4.20257 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.13577 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC |
4.07844 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CHRM3, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SLC1A1, SRC, TOP2A, XDH |
4.07489 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EDNRA, ESR1, FABP3, FABP4, FLT3, FUT7, GAA, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, HSD17B1, HSD17B2, IGF1R, KDR, MET, MGAM, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TOP2A, TYR, XDH |
4.03863 |
[BP] GO:0030818 |
None
|
EDNRA, GRM3, GRM8, HRH3, HRH4 |
3.97846 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FLT3, GRIK5, GRM1, GRM5, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
3.91563 |
[BP] GO:0030803 |
None
|
EDNRA, GRM3, GRM8, HRH3, HRH4 |
3.89925 |
[BP] GO:0007200 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, ESR1, GRM5 |
3.85966 |
[BP] GO:0030815 |
None
|
EDNRA, GRM3, GRM8, HRH3, HRH4 |
3.82004 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, CDC25B, CHRM1, CHRNA7, CSNK2A1, CYP1B1, ESR1, FABP3, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1, PTGS1, PTGS2, SRC, XDH |
3.80639 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, AURKB, CDC25B, CHRNA3, CHRNA7, CSNK2A1, EDNRA, ESR1, FABP4, FLT3, GRM1, GRM3, GRM5, HRH3, HRH4, IGF1R, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.80639 |
[BP] GO:1900372 |
None
|
EDNRA, GRM3, GRM8, HRH3, HRH4 |
3.79254 |
[BP] GO:0030809 |
None
|
EDNRA, GRM3, GRM8, HRH3, HRH4 |
3.79254 |
[BP] GO:0030800 |
None
|
EDNRA, GRM3, GRM8, HRH3, HRH4 |
3.7619 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AURKB, AXL, CHRNA7, CSNK2A1, CYP1B1, ESR1, FLT3, GRM1, HRH4, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.73835 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, HRH4, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
3.73692 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, PPARA, PTGS1, PTGS2 |
3.70278 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.70099 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FABP4, FUT7, GAA, MGAM, MMP1, MMP2, MMP9, PIK3CB, SRC, XDH |
3.70014 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, HRH4, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.64262 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2 |
3.6289 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FABP3, FLT3, GRM1, GRM5, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.6069 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FABP3, FLT3, GRM1, GRM5, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.6069 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.60345 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, FABP3, FLT3, HSD17B2, PTGS2, SRC, TYR |
3.5912 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2 |
3.5912 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
3.59051 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AXL, CHRNA7, CYP1B1, FLT3, GRM1, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.57091 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC |
3.53031 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, AURKB, CDC25B, CHRNA3, CHRNA7, CSNK2A1, CYP1B1, CYP2D6, EDNRA, ESR1, FABP4, FLT3, GRM1, GRM3, GRM5, HRH3, HRH4, IGF1R, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, XDH |
3.52214 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CHRNA3, CYP19A1, CYP1A1, CYP1B1, ESR1, HCAR2, HSD17B1, HSD17B2 |
3.52214 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.51493 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, PIK3CA, PIK3CB, PTPN1, SRC |
3.48701 |
[BP] GO:0007267 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.46823 |
[BP] GO:0007154 |
None
|
ADORA1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, PTGS2, SLC1A1 |
3.46563 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRNA3, GAA, GRM1, HCAR2, PTGS2, SLC1A1 |
3.45799 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.43642 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, PIK3CA, PTGS2, SRC |
3.42144 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, AXL, CA2, CA7, CHRM1, CHRNA3, CSNK2A1, CYP19A1, CYP1B1, GRIK5, GRM5, HCAR2, HRH3, IGF1R, KDR, MET, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SRC |
3.42032 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CHRM5, CHRNA3, CHRNA7, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1 |
3.39194 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, NQO2, PTGS1 |
3.31636 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, FABP3, PPARA, SLC1A1 |
3.27917 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, PIK3CA, PTGS2, SRC |
3.26847 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EDNRA, ESR1, FLT3, HSD17B2, KDR, PIK3CA, PPARA, SRC, TYR |
3.26516 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, PIK3CA, PIK3CB, PTPN1, SRC |
3.26438 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CHRNA7, CYP1A1, EDNRA, MMP2, PPARA, PTGS2, SRC |
3.24792 |
[BP] GO:0019725 |
cellular homeostasis
|
APEX1, CA2, CA7, CHRNA7, EDNRA, ESR1, GAA, GRIK5, GRM1, GRM5, HRH4, PIK3CA, PIK3CB |
3.24792 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
3.2359 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, IGF1R, PIK3CA, PIK3CB, PTPN1, SRC |
3.2359 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, CA1, CSNK2A1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
3.2359 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, CHRNA7, FABP3, GRM5, IGF1R, PPARA, PTGS2, SRC |
3.23573 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.17009 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.17009 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CHRNA7, CYP1A1, EDNRA, MMP2, PPARA, PTGS2, SRC |
3.17009 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, PIK3CA, PTGS2, SRC |
3.15522 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EDNRA, ESR1, FABP3, FABP4, FLT3, GAA, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TOP2A, XDH |
3.15363 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, PIK3CA, PIK3CB, PTPN1, SRC |
3.13996 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
3.11751 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CHRM5, CYP1A1, FABP3, FLT3, HCAR2, PPARA, PTGS2, SRC |
3.11751 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, CHRM1, CHRM3, CHRM5, CHRNA7, CYP1B1, EDNRA, GAA, GRM1, GRM5, GRM8, HRH3, PIK3CA, PTGS2, SRC, TYR |
3.08204 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, CHRNA3, CHRNA7, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
3.08023 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.08023 |
[BP] GO:0023052 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.07181 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GLO1, PPARA, PTGS1, PTGS2 |
3.01055 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, GAA, PTGS2, SLC1A1 |
2.99649 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APEX1, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MMP2, MMP9, PIK3CA, PTGS2, PTPN1, SRC, TOP2A |
2.95792 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, IGF1R, PIK3CA, PIK3CB, PTPN1, SRC |
2.94586 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CHRNA7, CYP1A1, EDNRA, MMP2, PPARA, PTGS2, SRC |
2.93982 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, PTGS2, SRC, TYR |
2.9231 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5, HRH3 |
2.875 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CA9, CHRNA3, CHRNA7, CYP1A1, CYP1B1, FABP3, KDR, PTGS2, SRC |
2.86815 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AXL, CA2, CHRM1, CHRM2, CHRM3, CHRNA3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, ESR1, FLT3, GAA, HSD17B2, KDR, MMP9, PIK3CA, PIM1, PPARA, PTGS2, SRC, TYR |
2.8604 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.85268 |
[BP] GO:0042391 |
None
|
ADORA1, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
2.8261 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, IGF1R, PIK3CA, PIK3CB, PTPN1, SRC |
2.81374 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CDC25B, CHRM1, CHRNA7, CSNK2A1, ESR1, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1, PTGS2 |
2.77873 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.7621 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, CHRNA7, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
2.7434 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, CHRNA3, CHRNA7, GRM1, PIK3CA, PIK3CB, PTPN1, SRC |
2.72948 |
[BP] GO:0003018 |
None
|
ADORA1, CHRM1, CHRM3, EDNRA, PTGS2, SRC |
2.65784 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
CA2, CA7, CHRNA7, EDNRA, ESR1, GRIK5, GRM1, GRM5, HRH4, PIK3CA, PIK3CB |
2.64368 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AXL, CHRNA7, CSNK2A1, CYP1B1, FLT3, GRM1, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.64368 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.61741 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.59406 |
[BP] GO:0006937 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRNA3, PTGS2 |
2.57713 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EDNRA, ESR1, FABP3, FABP4, FLT3, GAA, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TOP2A, XDH |
2.57693 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, EDNRA, ESR1, FABP3, FABP4, GLO1, GRM3, GRM8, HRH3, HRH4, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
2.57693 |
[BP] GO:0050801 |
ion homeostasis
|
CA12, CA2, CA7, CHRNA7, EDNRA, ESR1, FABP3, GRM1, GRM5, HRH4, PIK3CB |
2.56196 |
[BP] GO:0030817 |
None
|
EDNRA, GRM3, GRM8, HRH3, HRH4 |
2.5471 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
2.53839 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, FLT3, FUT7, GAA, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MGAM, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH |
2.51506 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, CHRNA7, FLT3, GRM1, IGF1R, PIK3CB, PTPN1, SRC |
2.51506 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, PTGS1, PTGS2, SRC |
2.48992 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CHRNA3, CYP1B1, GRIK5, HRH3, PTGS2, SLC1A1 |
2.43742 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.43742 |
[BP] GO:0000023 |
None
|
GAA, MGAM |
2.43742 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.43742 |
[BP] GO:1905144 |
None
|
CHRNA3, CHRNA7 |
2.43742 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.42874 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.39986 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, HRH4, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.39275 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FABP3, GAA, GRIA2, GRIA4, GRIK5, HRH3, MGAM, MMP9, PPARA, SLC1A1, SRC, XDH |
2.38779 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.38779 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, CHRNA7, FLT3, GRM1, PIK3CB, PTPN1, SRC |
2.36889 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, CDC25B, CHRNA3, CHRNA7, CSNK2A1, ESR1, FLT3, GRM1, GRM5, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.34079 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, CHRNA7, FLT3, GRM1, HRH4, IGF1R, KDR, PIK3CB, PTPN1, SRC, XDH |
2.33798 |
[BP] GO:0045936 |
None
|
EDNRA, FABP4, GRM3, GRM8, HRH3, HRH4, IGF1R, PPARA, PTPN1, XDH |
2.33536 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, HCAR2, KDR, PIK3CB, PTGS2, SRC |
2.33532 |
[BP] GO:0010563 |
None
|
EDNRA, FABP4, GRM3, GRM8, HRH3, HRH4, IGF1R, PPARA, PTPN1, XDH |
2.33348 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.32142 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.31292 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, EDNRA, ESR1, FABP3, FABP4, GLO1, GRM3, GRM8, HCAR2, HRH3, HRH4, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
2.30935 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, CA2, CHRNA7, CYP1A1, EDNRA, GRM1, MMP2, PPARA, PTGS2, SRC, TYR |
2.3063 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.3063 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.3063 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.3063 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP2D6 |
2.27842 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, FLT3, FUT7, GAA, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MGAM, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH |
2.27771 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.27297 |
[BP] GO:0030814 |
None
|
EDNRA, GRM3, GRM8, HRH3, HRH4 |
2.27257 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FABP3, GAA, GRIA2, GRIA4, GRIK5, HRH3, MGAM, MMP9, PPARA, SLC1A1, SRC, XDH |
2.26542 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, AURKB, CHRNA7, CSNK2A1, CYP2D6, EDNRA, ESR1, FABP4, GRM3, GRM8, HCAR2, HRH3, HRH4, IGF1R, KDR, MET, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, SRC, XDH |
2.25579 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, ESR1, FABP3, GAA, GRIA2, GRIA4, GRIK5, HRH3, MGAM, MMP9, PPARA, SLC1A1, SRC, XDH |
2.25301 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.23473 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.23473 |
[BP] GO:0030802 |
None
|
EDNRA, GRM3, GRM8, HRH3, HRH4 |
2.23133 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, PTGS2, SRC |
2.23133 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, AURKB, CA9, CDC25B, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EDNRA, ESR1, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
2.22954 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.22669 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.21899 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AXL, CA2, CA9, CHRNA7, CYP1A1, CYP1A2, CYP1B1, EDNRA, HRH4, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SRC, TOP2A |
2.21471 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.21471 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.21471 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.21471 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.21471 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, CHRNA7, PTGS2 |
2.2146 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, CHRM1, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.20718 |
[BP] GO:0050877 |
None
|
ADORA1, CHRM1, CHRM5, CHRNA7, CYP1B1, GAA, GRM1, GRM5, GRM8, HRH3, PTGS2, TYR |
2.20104 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, CA2, CA7, CHRM1, CHRNA3, CYP19A1, GRIK5, GRM5, HCAR2, HRH3, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SRC |
2.19459 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC |
2.1886 |
[BP] GO:0046903 |
None
|
ALOX5, AXL, CA2, CA9, CHRM1, CHRM3, CHRM5, GAA, HRH3, MGAM, MMP9, SLC1A1, XDH |
2.18375 |
[BP] GO:0097746 |
None
|
ADORA1, CHRM1, CHRM3, EDNRA, PTGS2 |
2.17715 |
[BP] GO:0035296 |
None
|
ADORA1, CHRM1, CHRM3, EDNRA, PTGS2 |
2.17715 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.17715 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.16457 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.16457 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, CHRNA7, FLT3, GRM1, KDR, PIK3CB, PTPN1, SRC, XDH |
2.16109 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, EDNRA, ESR1, FABP3, FABP4, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SRC, TOP2A, XDH |
2.16109 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, CDC25B, CHRNA3, CHRNA7, ESR1, FLT3, GRM1, GRM5, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.15106 |
[BP] GO:0003013 |
None
|
ADORA1, CHRM1, CHRM3, EDNRA, PTGS2, SRC |
2.13638 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.13558 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CHRNA7, CYP1A1, CYP1B1, KDR, SRC |
2.13301 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
CA12, CA2, CA7, CHRNA7, EDNRA, ESR1, GRM1, GRM5, HRH4, PIK3CB |
2.1274 |
[BP] GO:1900371 |
None
|
EDNRA, GRM3, GRM8, HRH3, HRH4 |
2.1162 |
[BP] GO:0030808 |
None
|
EDNRA, GRM3, GRM8, HRH3, HRH4 |
2.10184 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.09285 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1 |
2.08483 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, MET, PIK3CA, PIK3CB, SRC, XDH |
2.08072 |
[BP] GO:0050880 |
None
|
ADORA1, CHRM1, CHRM3, EDNRA, PTGS2 |
2.07841 |
[BP] GO:0035150 |
None
|
ADORA1, CHRM1, CHRM3, EDNRA, PTGS2 |
2.06518 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, AURKB, CDC25B, CHRNA3, CHRNA7, EDNRA, ESR1, FLT3, GRM1, GRM5, MET, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, XDH |
2.04433 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.04433 |
[BP] GO:0014050 |
None
|
ADORA1, HRH3 |
2.04433 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, AXL, CA2, CHRM1, CHRM2, CHRM3, CHRNA3, CHRNA7, CYP1B1, ESR1, GAA, GRM1, HCAR2, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, SLC1A1, SRC, XDH |
2.03312 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
CHRM5, FABP3, FLT3, SRC |
2.02692 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.00327 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, MGAM, PTGS2, SLC1A1, SRC |
8.15888 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, EDNRA, ESR1, FLT3, GAA, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, IGF1R, KDR, MET, MGAM, MMP2, PIK3CA, PIK3CB, PIM1, PTPN1, SLC1A1, SRC |
7.5423 |
[CC] GO:0097060 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.47515 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HRH3, SRC |
6.63799 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EDNRA, ESR1, FLT3, FUT7, GAA, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, HSD17B2, IGF1R, KDR, MET, MGAM, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TYR |
5.99168 |
[CC] GO:0045211 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM3 |
5.70175 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HRH3, IGF1R, KDR, MET, MGAM, PTGS2, SLC1A1, SRC |
5.29595 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EDNRA, ESR1, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, HSD17B2, IGF1R, KDR, MET, MGAM, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TYR |
4.93119 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, EDNRA, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HRH3, IGF1R, KDR, MET, SLC1A1 |
4.41402 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EDNRA, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HRH3, IGF1R, KDR, MET, SLC1A1 |
4.09641 |
[CC] GO:0014069 |
None
|
ADORA1, CHRM1, CHRNA3, GRIK5, GRM1, GRM3, GRM5, SRC |
3.94404 |
[CC] GO:0099572 |
None
|
ADORA1, CHRM1, CHRNA3, GRIK5, GRM1, GRM3, GRM5, SRC |
3.94404 |
[CC] GO:0043005 |
None
|
ADORA1, CA2, CHRM1, CHRM2, CHRM3, CHRNA3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTGS2, SRC |
3.82004 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.39194 |
[CC] GO:0097458 |
None
|
ADORA1, CA2, CHRM1, CHRM2, CHRM3, CHRNA3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HRH3, PTGS1, PTGS2, SRC |
3.04264 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, CA2, CHRM1, CHRM2, CHRM3, CHRNA3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2, SRC |
2.8155 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, CA2, CHRM1, CHRM2, CHRM3, CHRNA3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2, SRC |
2.5471 |
[CC] GO:0098793 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, GRIK5, HRH3 |
2.51646 |
[CC] GO:0098802 |
None
|
CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1 |
2.42874 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, CA4, CA9, CHRM1, CHRM2, CHRM3, GRIA2, GRIA4, GRIK5, GRM3, PTGS1, SRC |
2.1447 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, CA4, CA9, CHRM1, CHRM2, CHRM3, GRIA2, GRIA4, GRIK5, GRM3, PTGS1, SRC |
2.1447 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HRH3, HRH4 |
11.8694 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
11.8694 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, GLO1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTPN1, TYR, XDH |
9.04042 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CDC25B, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EDNRA, FLT3, FUT7, GAA, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MGAM, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH |
8.71339 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, IGF1R, KDR, MET, PPARA |
8.64198 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, IGF1R, KDR, MET |
7.99962 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, IGF1R, KDR, MET |
7.99962 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.99962 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
7.92346 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, IGF1R, KDR, MET, PPARA |
7.80752 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, IGF1R, KDR, MET, PPARA |
7.57156 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
7.57156 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7 |
7.4494 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4, IGF1R, KDR, MET, PPARA |
7.09226 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FLT3, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, SRC, TOP2A |
6.35983 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.33347 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, GLO1 |
6.19794 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CHRM3, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, FLT3, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TOP2A, TYR, XDH |
6.14678 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, HRH3, HRH4 |
5.69093 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
5.63506 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.19516 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2, SRC |
5.15444 |
[MF] GO:0042562 |
hormone binding
|
ACHE, CHRM3, CHRNA3, CHRNA7, HSD17B1, IGF1R, NQO2 |
5.08465 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
4.94302 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2, SRC |
4.93119 |
[MF] GO:0008227 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, HRH3, HRH4 |
4.7655 |
[MF] GO:0004629 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5, EDNRA |
4.68679 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2, TYR |
4.6111 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA6, CA7, CA9, ESR1, GLO1, MMP1, MMP2, MMP9, NQO2, PPARA, PTPN1 |
4.38084 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CHRM3, CHRNA3, CHRNA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, GLO1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SLC1A1, TOP2A, TYR, XDH |
4.3009 |
[MF] GO:0042166 |
None
|
ACHE, CHRM3, CHRNA3, CHRNA7 |
4.11895 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
3.94032 |
[MF] GO:0005231 |
None
|
CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 |
3.82004 |
[MF] GO:0098960 |
None
|
CHRNA3, CHRNA7, GRM1, GRM5 |
3.79254 |
[MF] GO:0008081 |
None
|
ADORA1, APEX1, CHRM1, CHRM3, CHRM5, EDNRA |
3.77675 |
[MF] GO:0022824 |
None
|
CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 |
3.7619 |
[MF] GO:0022835 |
None
|
CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 |
3.7619 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, NQO2, PTGS1, PTGS2, SRC, XDH |
3.70014 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
3.70014 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, XDH |
3.56152 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, EDNRA, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH3, HRH4 |
3.45799 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5, EDNRA |
3.43642 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.39194 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
3.05965 |
[MF] GO:0005230 |
None
|
CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 |
3.04476 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.94586 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.84657 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, GLO1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SLC1A1, TOP2A, TYR, XDH |
2.61022 |
[MF] GO:0004620 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5, EDNRA |
2.47515 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, CHRM3, CHRNA3, CHRNA7 |
2.43774 |
[MF] GO:0032450 |
None
|
GAA, MGAM |
2.43742 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.43742 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.4061 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.4061 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.38779 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.34956 |
[MF] GO:0042578 |
None
|
ADORA1, APEX1, CDC25B, CHRM1, CHRM3, CHRM5, EDNRA, PTPN1 |
2.33536 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.21471 |
[MF] GO:0004558 |
None
|
GAA, MGAM |
2.21471 |
[MF] GO:0016788 |
None
|
ACHE, ADORA1, APEX1, CA1, CA2, CDC25B, CHRM1, CHRM3, CHRM5, EDNRA, PTPN1 |
2.20584 |
[MF] GO:0016298 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5, EDNRA |
2.14093 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.08522 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIM1, SRC |
2.07841 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HSD17B1, HSD17B2, XDH |
2.02692 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, CHRM3, CHRNA3, CHRNA7 |
2.00501 |